Literature DB >> 6218367

Left ventricular size following endurance, sprint, and strength training.

G Ricci, D Lajoie, R Petitclerc, F Peronnet, R J Ferguson, M Fournier, A W Taylor.   

Abstract

Left ventricular size following endurance, sprint, and strength training. Med. Sci. Sports Exercise, Vol. 14, No. 5, pp. 344-347, 1982. Left ventricular dimensions in adolescent boys were determined before and after three types of training regimens: endurance (END), N = 8, means = 16.8 yr; sprint (SPR), N = 8, means = 16.3 yr; strength (STR), N = 12, means = 18.7 yr. With training the END group significantly increased VO2max in 1 X min-1 (3.71 +/- 0.27 to 4.16 +/- 0.57, P less than 0.05) and in ml X min-1 X kg-1 (58.4 +/- 5.6 to 64.2 +/- 5.5, P less than 0.05). The SPR group increased VO2max in 1 X min-1 (3.63 +/- 0.63 to 3.98 +/- 0.78, P less than 0.05) but not in ml X min-1 X kg-1 (59.5 +/- 4.1 to 63.2 +/- 5.4) because body weight increased from 61.2 +/- 10.5 to 63.1 +/- 10.7 kg (P less than 0.05) with no change in percent body fat. The STR training group significantly improved upper body strength. Despite these specific training adaptations no significant modifications were found for interventricular and left ventricular posterior wall thickness or for left ventricular internal diameter in either training group. However, calculated left ventricular mass was slightly but significantly higher by 10% and 4% in the END and STR training groups, respectively. These small increases in calculated left ventricular mass with short-term training are probably caused by small but insignificant increases in left ventricular internal diameter secondary to a training bradycardia (END group: 76 +/- 8 to 64 +/- 1 beats X min-1) and to increased diastolic filling time rather than to true cardiac hypertrophy. Significant increases in aerobic capacity and in strength can occur without modification of left ventricular dimensions.

Entities:  

Mesh:

Year:  1982        PMID: 6218367

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  10 in total

Review 1.  Resistance training and cardiac hypertrophy: unravelling the training effect.

Authors:  Mark J Haykowsky; Rudolph Dressendorfer; Dylan Taylor; Sandra Mandic; Dennis Humen
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Echocardiographic findings in strength- and endurance-trained athletes.

Authors:  A Urhausen; W Kindermann
Journal:  Sports Med       Date:  1992-04       Impact factor: 11.136

Review 3.  Musculoskeletal fitness, health outcomes and quality of life.

Authors:  R T Kell; G Bell; A Quinney
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 4.  Resistive exercise training in cardiac patients. Recommendations.

Authors:  D Verrill; E Shoup; G McElveen; K Witt; D Bergey
Journal:  Sports Med       Date:  1992-03       Impact factor: 11.136

Review 5.  Seasonal variation in fitness parameters in competitive athletes.

Authors:  Y Koutedakis
Journal:  Sports Med       Date:  1995-06       Impact factor: 11.136

Review 6.  Resistive exercise training in cardiac rehabilitation. An update.

Authors:  D E Verrill; P M Ribisl
Journal:  Sports Med       Date:  1996-05       Impact factor: 11.136

7.  Weight loss and exercise training effect on oxygen uptake and heart rate response to locomotion.

Authors:  Gary R Hunter; Gordon Fisher; David R Bryan; Paul A Zuckerman
Journal:  J Strength Cond Res       Date:  2012-05       Impact factor: 3.775

Review 8.  Health- and performance-related potential of resistance training.

Authors:  M H Stone; S J Fleck; N T Triplett; W J Kraemer
Journal:  Sports Med       Date:  1991-04       Impact factor: 11.136

Review 9.  The electrocardiogram and the athlete.

Authors:  J A Ferst; B R Chaitman
Journal:  Sports Med       Date:  1984 Sep-Oct       Impact factor: 11.136

Review 10.  The 'athletic heart syndrome'. A critical review.

Authors:  K P George; L A Wolfe; G W Burggraf
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.